These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
437 related items for PubMed ID: 12717241
1. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice. Lee MK, Huang X, Jarrett BP, Moore DJ, Desai NM, Moh Lian M, Markmann JW, Deng S, Frank A, Singer A, Velidedeoglu E, Caton AJ, Markmann AJ. Transplantation; 2003 Apr 27; 75(8):1415-22. PubMed ID: 12717241 [Abstract] [Full Text] [Related]
2. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells. Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler J, Tu F, Flye MW. Surgery; 2000 Aug 27; 128(2):206-12. PubMed ID: 10922993 [Abstract] [Full Text] [Related]
3. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL. Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596 [Abstract] [Full Text] [Related]
4. Allograft rejection in athymic nude rats by transferred T cell subsets. II. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to an isolated MHC class I disparity. Bell EB, Rejali D, Whitby EH, Sparshott SM, Yang CP. Transplantation; 1990 Oct 15; 50(4):690-6. PubMed ID: 1977220 [Abstract] [Full Text] [Related]
5. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse. Margenthaler JA, Flye MW. J Surg Res; 2005 Jun 15; 126(2):160-6. PubMed ID: 15919414 [Abstract] [Full Text] [Related]
6. Immunogenicity of L(d+) transgenic mouse hearts. Margenthaler JA, Tu F, Otomo N, Shimizu Y, Yu S, Flye MW. Surgery; 2001 Aug 15; 130(2):217-24. PubMed ID: 11490352 [Abstract] [Full Text] [Related]
7. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells. Kapessidou Y, Habran C, Buonocore S, Flamand V, Barvais L, Goldman M, Braun MY. Transplantation; 2006 Aug 27; 82(4):582-91. PubMed ID: 16958183 [Abstract] [Full Text] [Related]
8. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities. Youssef AR, Otley C, Mathieson PW, Smith RM. Transpl Immunol; 2004 Dec 27; 13(4):297-304. PubMed ID: 15589743 [Abstract] [Full Text] [Related]
9. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent. Coulombe M, Yang H, Wolf LA, Gill RG. J Immunol; 1999 Mar 01; 162(5):2503-10. PubMed ID: 10072489 [Abstract] [Full Text] [Related]
10. Adoptive immunity in immune-deficient scid/scid mice. I. Differential requirements of naive and primed lymphocytes for CD4+ T cells during rejection of minor histocompatibility antigen-disparate skin grafts. Roopenian DC, Anderson PS. Transplantation; 1988 Dec 01; 46(6):899-904. PubMed ID: 2905088 [Abstract] [Full Text] [Related]
11. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. Dalloul AH, Chmouzis E, Ngo K, Fung-Leung WP. J Immunol; 1996 Jun 01; 156(11):4114-9. PubMed ID: 8666777 [Abstract] [Full Text] [Related]
12. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection. Brennan TV, Hoang V, Garrod KR, Liu FC, Hayden T, Kim J, Kang SM. Transplantation; 2008 Jan 27; 85(2):247-55. PubMed ID: 18212630 [Abstract] [Full Text] [Related]
13. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors. Marzo AL, Lake RA, Robinson BW, Scott B. Cancer Res; 1999 Mar 01; 59(5):1071-9. PubMed ID: 10070965 [Abstract] [Full Text] [Related]
14. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells. Kapessidou Y, Habran C, Buonocore S, Flamand V, Barvais L, Goldman M, Braun MY. Transplantation; 2006 Mar 15; 81(5):726-35. PubMed ID: 16534475 [Abstract] [Full Text] [Related]
15. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells. Bot A, Casares S, Bot S, von Boehmer H, Bona C. J Immunol; 1998 May 01; 160(9):4500-7. PubMed ID: 9574556 [Abstract] [Full Text] [Related]
16. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection. Haskova Z, Sproule TJ, Roopenian DC, Ksander AB. Transplantation; 2003 Apr 27; 75(8):1368-74. PubMed ID: 12717232 [Abstract] [Full Text] [Related]
17. A direct comparison of rejection by CD8 and CD4 T cells in a transgenic model of allotransplantation. Porrett PM, Lee MK, Lian MM, Wang J, Caton AJ, Deng S, Markmann JF, Moore DJ. Arch Immunol Ther Exp (Warsz); 2008 Apr 27; 56(3):193-200. PubMed ID: 18512028 [Abstract] [Full Text] [Related]
18. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, Okumura K, Yagita H, Kawai K. Int Immunol; 2008 Oct 27; 20(10):1343-9. PubMed ID: 18697765 [Abstract] [Full Text] [Related]
19. A novel model of allograft rejection: immune reconstitution of Rag-1 recipients with 2C transgenic T-cell receptor lymphocytes. Ninova D, Dean PG, Deeds M, Stegall MD. Transpl Int; 2005 Jan 27; 18(1):101-10. PubMed ID: 15612991 [Abstract] [Full Text] [Related]